asa guidelines on glp 1 GLP-1 agonists and anesthesia risk: Assessment of gastric content using ultrasound Glucagon-Like Peptide 1 Receptor Agonists
Description
Industry Insights These industry-specific articles explore the top risks, their underlying drivers and the actions leaders are taking to build resilience
Baggio, Email: [email protected]
A huge driver of patients not refilling their prescriptions is due to the high cost of these medications
Research continues into optimizing dosing protocols for different patient populations, including those with specific metabolic conditions
2 Metabolic models Scientists evaluate glucose tolerance, insulin sensitivity, and pancreatic beta cell function in type 2 diabetes mouse models
